JP2014101346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014101346A5 JP2014101346A5 JP2013087322A JP2013087322A JP2014101346A5 JP 2014101346 A5 JP2014101346 A5 JP 2014101346A5 JP 2013087322 A JP2013087322 A JP 2013087322A JP 2013087322 A JP2013087322 A JP 2013087322A JP 2014101346 A5 JP2014101346 A5 JP 2014101346A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- ginger
- active ingredient
- muscle
- endurance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 12
- 241000234314 Zingiber Species 0.000 claims 11
- 235000006886 Zingiber officinale Nutrition 0.000 claims 11
- 235000008397 ginger Nutrition 0.000 claims 11
- 239000004480 active ingredient Substances 0.000 claims 7
- 210000003205 Muscles Anatomy 0.000 claims 6
- 238000011084 recovery Methods 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000001737 promoting Effects 0.000 claims 4
- 229940002508 Ginger extract Drugs 0.000 claims 3
- 206010028289 Muscle atrophy Diseases 0.000 claims 3
- 210000002027 Muscle, Skeletal Anatomy 0.000 claims 3
- 235000020708 ginger extract Nutrition 0.000 claims 3
- 230000020763 muscle atrophy Effects 0.000 claims 3
- 201000000585 muscular atrophy Diseases 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 235000013361 beverage Nutrition 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Claims (11)
- ショウガまたはその抽出物を有効成分とする骨格筋遅筋化剤。
- ショウガまたはその抽出物を有効成分とする持久力改善剤。
- ショウガまたはその抽出物を有効成分とする筋量改善剤。
- ショウガまたはその抽出物を有効成分とする持久力回復促進剤。
- ショウガまたはその抽出物を有効成分とする筋量回復促進剤。
- ショウガまたはその抽出物を有効成分とする筋委縮抑制剤。
- ショウガまたはその抽出物を有効量で投与するかまたは摂取させることを含む、骨格筋遅筋化、持久力改善、筋量改善、持久力回復促進、筋量回復促進または筋委縮抑制のための非治療的方法。
- ショウガまたはその抽出物を有効成分とする、骨格筋遅筋化用、持久力改善用、筋量改善用、持久力回復促進用、筋量回復促進用または筋委縮抑制用の飲食品組成物。
- ショウガ抽出物がショウガの水、エタノールまたはエタノール水溶液の抽出物である、請求項１〜６のいずれか１項記載の剤。
- ショウガ抽出物がショウガの水、エタノールまたはエタノール水溶液の抽出物である、請求項７記載の方法。
- ショウガ抽出物がショウガの水、エタノールまたはエタノール水溶液の抽出物である、請求項８記載の飲食品組成物。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013087322A JP6126443B2 (ja) | 2012-06-08 | 2013-04-18 | 骨格筋遅筋化剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012131003 | 2012-06-08 | ||
| JP2012131003 | 2012-06-08 | ||
| JP2012233861 | 2012-10-23 | ||
| JP2012233861 | 2012-10-23 | ||
| JP2013087322A JP6126443B2 (ja) | 2012-06-08 | 2013-04-18 | 骨格筋遅筋化剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014101346A JP2014101346A (ja) | 2014-06-05 |
| JP2014101346A5 true JP2014101346A5 (ja) | 2016-05-12 |
| JP6126443B2 JP6126443B2 (ja) | 2017-05-10 |
Family
ID=49712133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013087322A Active JP6126443B2 (ja) | 2012-06-08 | 2013-04-18 | 骨格筋遅筋化剤 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP6126443B2 (ja) |
| CN (1) | CN104349786B (ja) |
| WO (1) | WO2013183747A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016072992A1 (en) * | 2014-11-06 | 2016-05-12 | NWO Stem Cure, LLC | Nutraceutical supplement with lactobacillus rhamnosus |
| JP6924486B2 (ja) * | 2017-06-30 | 2021-08-25 | 株式会社東洋新薬 | 食品組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002047702A1 (en) * | 2000-12-15 | 2002-06-20 | Naturalendo Tech Co., Ltd. | Compositions for inducing secretion of insulin-like growth factor-1 |
| JP2003310200A (ja) * | 2002-04-22 | 2003-11-05 | ▲高▼島 広雄 | ショウガの加工方法 |
| JP2006328031A (ja) * | 2005-05-30 | 2006-12-07 | Asahi Breweries Ltd | 筋繊維タイプ移行抑制剤 |
| JP5303697B2 (ja) * | 2005-10-26 | 2013-10-02 | オリザ油化株式会社 | 抗炎症剤 |
| AU2007333048A1 (en) * | 2006-12-14 | 2008-06-19 | The Quigley Corporation | Compositions and methods for treating infectious bronchitis |
| KR101698201B1 (ko) * | 2010-05-20 | 2017-01-19 | (주)뉴트리 | 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물을 포함하는 근육 증가 촉진, 항-피로 및 운동수행능력 향상용 조성물 |
-
2013
- 2013-04-18 JP JP2013087322A patent/JP6126443B2/ja active Active
- 2013-06-07 WO PCT/JP2013/065785 patent/WO2013183747A1/ja active Application Filing
- 2013-06-07 CN CN201380030075.8A patent/CN104349786B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| DOP2015000012A (es) | Acidos 5-aminotetrahidroquinolin-2-carboxilicos novedosos y su uso | |
| ECSP11011278A (es) | Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente. | |
| HN2011002406A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
| CL2013001947A1 (es) | Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona. | |
| CL2013003372A1 (es) | Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes. | |
| JP2014218522A5 (ja) | ||
| CL2014000050A1 (es) | Composicion farmaceutica en forma de solucion que comprende apomorfina, un codisolvente micible en agua, un antioxidante y agua, en la que el ph es superior a 4; procedimiento para fabricarla; y su uso como solucion inyectable en el tratamiento de la enfermedad de parkinson. | |
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| BR112015032370A2 (pt) | derivados de biarila, composição, e, método para preparar uma composição | |
| WO2014153009A3 (en) | Thiosaccharide mucolytic agents | |
| WO2015095735A3 (en) | Vaccine compositions and uses thereof | |
| WO2015056094A3 (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent | |
| WO2012037562A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
| WO2014107730A3 (en) | Use of fatty acid niacin conjugates for treating diseases | |
| BR112016024020A8 (pt) | composição farmacêutica | |
| WO2014121764A3 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
| EA201491532A1 (ru) | Фармацевтические композиции для использования в комплексной терапии | |
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| JP2012217972A5 (ja) | ||
| JP2014101346A5 (ja) | ||
| UY36064A (es) | Derivados quirales de ácido ciclopentancarboxílico 2,5-disustituidos y su uso | |
| BR112014004737A2 (pt) | composto de composição de cloridrato de ambroxol e método de preparação do composto | |
| JP2015107925A5 (ja) | ||
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses |